< Back | |
12 May 2016 | |
Glenmark Pharmaceuticals Ltd has informed BSE that the Nomination and Remuneration Committee of the Company, at its meeting held on May 12, 2016 has cancelled 27,500 stock options pursuant to ESOS 2003. | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |